US Stock MarketDetailed Quotes

CGON CG Oncology

Watchlist

32.340
+0.100+0.31%

Close Nov 21 16:00 ET

32.380
+0.040+0.12%

Pre 08:00 ET

2.19BMarket Cap-27879P/E (TTM)

CG Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

377.78%43K

111K

172.68%529K

6.81%204K

194K

-98.16%191K

Operating revenue

377.78%43K

--111K

172.68%529K

6.81%204K

--1K

--9K

--0

--194K

-98.16%191K

--0

Cost of revenue

Gross profit

Operating expense

101.67%28.34M

110.64%25.96M

131.95%23M

57.05%55.65M

107.79%19.36M

14.05M

12.33M

9.92M

54.32%35.44M

9.32M

Selling and administrative expenses

276.18%8.72M

200.48%7.49M

179.21%5.79M

54.51%9.9M

82.02%3.02M

--2.32M

--2.49M

--2.07M

37.95%6.41M

--1.66M

-General and administrative expense

276.18%8.72M

200.48%7.49M

179.21%5.79M

54.51%9.9M

82.02%3.02M

--2.32M

--2.49M

--2.07M

37.95%6.41M

--1.66M

Research and development costs

67.21%19.62M

87.86%18.47M

119.46%17.21M

57.61%45.75M

113.37%16.34M

--11.74M

--9.83M

--7.84M

58.46%29.03M

--7.66M

Operating profit

-101.49%-28.3M

-109.74%-25.85M

-131.14%-22.47M

-57.32%-55.45M

-107.78%-19.36M

-14.04M

-12.33M

-9.72M

-179.60%-35.25M

-9.32M

Net non-operating interest income expense

245.69%7.89M

800.52%6.94M

430.21%5.55M

690,500.00%6.9M

208.13%2.8M

2.28M

771K

1.05M

99.78%-1K

910K

Non-operating interest income

245.69%7.89M

800.52%6.94M

430.21%5.55M

----

--2.28M

--771K

--1.05M

----

Total other finance cost

----

-690,500.00%-6.9M

----

--1K

---910K

Other net income (expense)

75.00%-2K

113.79%8K

-212.50%-9K

68.37%-62K

-130.77%-4K

-8K

-58K

-189.91%-196K

13K

Other non- operating income (expenses)

75.00%-2K

113.79%8K

-212.50%-9K

68.37%-62K

-130.77%-4K

---8K

---58K

--8K

-189.91%-196K

--13K

Income before tax

-73.39%-20.41M

-62.77%-18.9M

-95.36%-16.93M

-37.14%-48.61M

-97.27%-16.56M

-11.77M

-11.61M

-8.67M

-176.06%-35.44M

-8.39M

Income tax

Net income

-73.39%-20.41M

-62.77%-18.9M

-95.36%-16.93M

-37.14%-48.61M

-97.27%-16.56M

-11.77M

-11.61M

-8.67M

-176.06%-35.44M

-8.39M

Net income continuous Operations

-73.39%-20.41M

-62.77%-18.9M

-95.36%-16.93M

-37.14%-48.61M

-97.27%-16.56M

---11.77M

---11.61M

---8.67M

-176.06%-35.44M

---8.39M

Minority interest income

Net income attributable to the parent company

-73.39%-20.41M

-62.77%-18.9M

-95.36%-16.93M

-37.14%-48.61M

-97.27%-16.56M

-11.77M

-11.61M

-8.67M

-176.06%-35.44M

-8.39M

Preferred stock dividends

129.97%19.19M

57.43%5.94M

5.75M

3.78M

3.73M

50.52%8.35M

3.77M

Other preferred stock dividends

Net income attributable to common stockholders

-16.51%-20.41M

-22.83%-18.9M

-36.54%-16.93M

-54.83%-67.8M

-84.92%-22.49M

-17.51M

-15.39M

-12.4M

-138.20%-43.79M

-12.16M

Basic earnings per share

-8.74%-0.3

-15.51%-0.28

87.43%-0.36

-33.65%-15.65

87.38%-0.3543

-0.2759

-0.2424

-2.8634

-2,046.69%-11.71

-2.8082

Diluted earnings per share

-8.74%-0.3

-15.51%-0.28

87.43%-0.36

-33.65%-15.65

87.38%-0.3543

-0.2759

-0.2424

-2.8634

-2,046.69%-11.71

-2.8082

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	377.78%43K	111K	172.68%529K	6.81%204K	1K	9K	0	194K	-98.16%191K	0
Operating revenue	377.78%43K	--111K	172.68%529K	6.81%204K	--1K	--9K	--0	--194K	-98.16%191K	--0
Cost of revenue
Gross profit
Operating expense	101.67%28.34M	110.64%25.96M	131.95%23M	57.05%55.65M	107.79%19.36M	14.05M	12.33M	9.92M	54.32%35.44M	9.32M
Selling and administrative expenses	276.18%8.72M	200.48%7.49M	179.21%5.79M	54.51%9.9M	82.02%3.02M	--2.32M	--2.49M	--2.07M	37.95%6.41M	--1.66M
-General and administrative expense	276.18%8.72M	200.48%7.49M	179.21%5.79M	54.51%9.9M	82.02%3.02M	--2.32M	--2.49M	--2.07M	37.95%6.41M	--1.66M
Research and development costs	67.21%19.62M	87.86%18.47M	119.46%17.21M	57.61%45.75M	113.37%16.34M	--11.74M	--9.83M	--7.84M	58.46%29.03M	--7.66M
Operating profit	-101.49%-28.3M	-109.74%-25.85M	-131.14%-22.47M	-57.32%-55.45M	-107.78%-19.36M	-14.04M	-12.33M	-9.72M	-179.60%-35.25M	-9.32M
Net non-operating interest income expense	245.69%7.89M	800.52%6.94M	430.21%5.55M	690,500.00%6.9M	208.13%2.8M	2.28M	771K	1.05M	99.78%-1K	910K
Non-operating interest income	245.69%7.89M	800.52%6.94M	430.21%5.55M	----	----	--2.28M	--771K	--1.05M	----	----
Total other finance cost	----	----	----	-690,500.00%-6.9M	----	----	----	----	--1K	---910K
Other net income (expense)	75.00%-2K	113.79%8K	-212.50%-9K	68.37%-62K	-130.77%-4K	-8K	-58K	8K	-189.91%-196K	13K
Other non- operating income (expenses)	75.00%-2K	113.79%8K	-212.50%-9K	68.37%-62K	-130.77%-4K	---8K	---58K	--8K	-189.91%-196K	--13K
Income before tax	-73.39%-20.41M	-62.77%-18.9M	-95.36%-16.93M	-37.14%-48.61M	-97.27%-16.56M	-11.77M	-11.61M	-8.67M	-176.06%-35.44M	-8.39M
Income tax
Net income	-73.39%-20.41M	-62.77%-18.9M	-95.36%-16.93M	-37.14%-48.61M	-97.27%-16.56M	-11.77M	-11.61M	-8.67M	-176.06%-35.44M	-8.39M
Net income continuous Operations	-73.39%-20.41M	-62.77%-18.9M	-95.36%-16.93M	-37.14%-48.61M	-97.27%-16.56M	---11.77M	---11.61M	---8.67M	-176.06%-35.44M	---8.39M
Minority interest income
Net income attributable to the parent company	-73.39%-20.41M	-62.77%-18.9M	-95.36%-16.93M	-37.14%-48.61M	-97.27%-16.56M	-11.77M	-11.61M	-8.67M	-176.06%-35.44M	-8.39M
Preferred stock dividends				129.97%19.19M	57.43%5.94M	5.75M	3.78M	3.73M	50.52%8.35M	3.77M
Other preferred stock dividends
Net income attributable to common stockholders	-16.51%-20.41M	-22.83%-18.9M	-36.54%-16.93M	-54.83%-67.8M	-84.92%-22.49M	-17.51M	-15.39M	-12.4M	-138.20%-43.79M	-12.16M
Basic earnings per share	-8.74%-0.3	-15.51%-0.28	87.43%-0.36	-33.65%-15.65	87.38%-0.3543	-0.2759	-0.2424	-2.8634	-2,046.69%-11.71	-2.8082
Diluted earnings per share	-8.74%-0.3	-15.51%-0.28	87.43%-0.36	-33.65%-15.65	87.38%-0.3543	-0.2759	-0.2424	-2.8634	-2,046.69%-11.71	-2.8082
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data